Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia.
about
Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathyArrhythmogenic ventricular cardiomyopathy: A paradigm shift from right to biventricular diseaseThe embryological basis of subclinical hypertrophic cardiomyopathyHypertrophic cardiomyopathy and sudden cardiac deathLong-term follow-up of children and adolescents diagnosed with hypertrophic cardiomyopathy: risk factors for adverse arrhythmic events.Increased amount of interstitial fibrosis predicts ventricular arrhythmias, and is associated with reduced myocardial septal function in patients with obstructive hypertrophic cardiomyopathy.Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: From Experiment to Standard of CareCurrent perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review.Prediction of the estimated 5-year risk of sudden cardiac death and syncope or non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy using late gadolinium enhancement and extracellular volume CMR.Serum Biomarkers of Myocardial Remodeling and Coronary Dysfunction in Early Stages of Hypertrophic Cardiomyopathy in the Young.Electrocardiographic amplitudes: a new risk factor for sudden death in hypertrophic cardiomyopathyUtility of T2-weighted short-tau inversion recovery (STIR) sequences in cardiac MRI: an overview of clinical applications in ischaemic and non-ischaemic heart disease.Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy.Myocardial edema imaging by cardiovascular magnetic resonance: current status and future potential.Coronary microvascular ischemia in hypertrophic cardiomyopathy - a pixel-wise quantitative cardiovascular magnetic resonance perfusion studyClinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy.Functional effects of a tropomyosin mutation linked to FHC contribute to maladaptation during acidosisMyocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.Genetics and clinical destiny: improving care in hypertrophic cardiomyopathyThe pathology of hypertrophic cardiomyopathy.Impaired mitochondrial biogenesis is a common feature to myocardial hypertrophy and end-stage ischemic heart failure.Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.Circulating matrix metalloproteinases in adolescents with hypertrophic cardiomyopathy and ventricular arrhythmia.Hypertrophic cardiomyopathy: refining the lens of cardiac magnetic resonance to evaluate late gadolinium enhancement.Heterogeneity of intramural function in hypertrophic cardiomyopathy: mechanistic insights from MRI late gadolinium enhancement and high-resolution displacement encoding with stimulated echoes strain maps.Regional Stress-Induced Ischemia in Non-fibrotic Hypertrophied Myocardium in Young HCM Patients.Hypertrophic cardiomyopathy: translating cellular cross talk into therapeuticsIntegrated microRNA‑gene analysis of coronary artery disease based on miRNA and gene expression profiles.Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy.Clinical Characteristics and Treatment of Cardiomyopathies in Children.T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophySurgical management of obstructive hypertrophic cardiomyopathy: the gold standard.Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives.Nuclear cardiac imaging in hypertrophic cardiomyopathy.The development of familial hypertrophic cardiomyopathy: from mutation to bedside.Mandatory ECG screening of athletes: is this question now resolved?Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations.Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association.Prevention of sudden death in hypertrophic cardiomyopathy: bridging the gaps in knowledge.ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy.
P2860
Q26999424-8211ED97-B23F-4E70-876C-A6E4F6CA465FQ27024037-3B448F12-48CB-4BF8-9859-1180E4B4C40DQ27342687-B1C63056-8A5D-4673-B48F-3F00034E5196Q30433865-B7172BBA-A5DF-4A06-B094-2A894540F7B0Q33159927-5F552B95-69FB-4391-9BF5-64F0125FAEDBQ33162387-8C5280CE-76A0-4C9D-8F83-8A0E2CAC5C8BQ33166450-F9FAEF52-5F34-411D-BC10-96E343533A2FQ33167509-20523805-3AF4-4287-B702-BD5376959C11Q33168755-5083EC73-542D-4217-BBC7-1B48F92BC289Q33554999-906DD4FB-5223-44DF-B636-B22201A7A773Q33651767-7546020F-45EC-461D-A673-3D5A5C012DD7Q33712217-6BE38131-72D0-4A2A-BDA4-BC5C7631C0E0Q33843181-5E580A13-B006-46B6-9239-786BC9A02E2BQ34090483-A7CBB24F-4C9F-4DA8-AF67-5736E692E3DAQ34091933-804A0108-15B3-43BB-B436-047BECDE718AQ34095709-BDDC4529-0895-4BC7-AC3F-318D85014715Q34561038-3B151EEC-6F7E-4A9A-9C98-80B3E2D774D1Q34629550-98BF9C55-73CC-483A-A7FA-6A344F96E963Q34999606-E0E75FD9-71D5-4735-9BD0-E170BC23E9FDQ35771667-9B6065AE-9CBE-441F-A861-A559214C6734Q35893494-95B2C471-AE52-4432-AAFB-6B67E54ECBC9Q36098649-414E6971-758C-4D81-AFCD-D6D95DA7EB67Q36160106-588690B4-F139-4D25-BB94-2AB8F1027095Q36203626-530FC3F4-D3FB-4E9F-AD76-409B919A347DQ36285946-9D2DB5B2-1EAD-43A6-9CD3-433376D5F435Q36305091-BB1864BD-0E37-4CF6-BCF6-7674123188DFQ36353490-843DF193-C2ED-43BC-952B-C4D925BDCCE6Q36722119-14E11F08-F5E4-46D1-B471-89947AD941DEQ36860996-4F2AF986-6606-4D47-877B-15880AEC74F6Q36886275-FB38D6CD-C5E9-4823-AB22-4D0BAE9B678FQ37160724-73352F13-B0C1-4A5D-83FA-FE982B2381FCQ37176455-DF05FCDF-02FF-48A1-B20D-C9B7B13EDC56Q37603719-B5225DDD-32DA-4A45-B249-6C1BEED3BC05Q37782285-7B58217C-1303-4177-869D-73F2A217382EQ37821051-187609FB-9EF7-4505-9D2C-12378BACB89CQ37953505-92E8AB88-92DD-4737-B9FB-0C5C4EB98AADQ38336102-97FB77EB-33F7-46C4-96CE-D2CE90A6A4A7Q38343713-CD81BE81-7F11-4A59-90A6-3FE6A205B8DFQ38884022-A3A35476-CD2A-458F-9A5C-7D11CFFDB372Q39003149-B90BDA4A-F19C-4C6F-BF0B-5C845D859018
P2860
Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Hypertrophic cardiomyopathy an ...... idence of myocardial ischemia.
@ast
Hypertrophic cardiomyopathy an ...... idence of myocardial ischemia.
@en
type
label
Hypertrophic cardiomyopathy an ...... idence of myocardial ischemia.
@ast
Hypertrophic cardiomyopathy an ...... idence of myocardial ischemia.
@en
prefLabel
Hypertrophic cardiomyopathy an ...... idence of myocardial ischemia.
@ast
Hypertrophic cardiomyopathy an ...... idence of myocardial ischemia.
@en
P2093
P356
P1433
P1476
Hypertrophic cardiomyopathy an ...... vidence of myocardial ischemia
@en
P2093
P304
P356
10.1053/HUPA.2000.16659
P407
P577
2000-08-01T00:00:00Z